|

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

RECRUITINGEarly 1Sponsored by University of Oklahoma
Actively Recruiting
PhaseEarly 1
SponsorUniversity of Oklahoma
Started2023-11-30
Est. completion2025-05-31
Eligibility
Age5 Years – 17 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06137040

Summary

This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

Eligibility

Age: 5 Years – 17 YearsHealthy volunteers accepted
Inclusion Criteria:

* Ages 5-17 years old
* Presents to the ED with a respiratory score in the "Moderate" range (6
* Parent(s)/Caregiver(s) speak English

Exclusion Criteria:

* Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
* Patients who are pregnant
* Parent(s)/Caregiver(s) do not speak English

Conditions3

AsthmaAsthma AttackAsthma in Children

Locations1 site

Oklahoma Children's Hospital
Oklahoma City, Oklahoma, 73104
Ryan McKee, MD405-271-2429Ryan-McKee@ouhsc.edu

Browse More Trials

Asthma trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.